Evidence map›Paper›PMID 18098289›Full record

ArticleInternational journal of cancer2008

Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP.

Nicole Nemetz, Catalina Abad, Greg Lawson, Hiroko Nobuta, Seririthanar Chhith, Lucy Duong, Gary Tse, Jonathan Braun, James A Waschek

Abstract read
In one paragraph

Article in International journal of cancer, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Protective Effects of PACAP in Peripheral Organs.Frontiers in endocrinology · 2020
    Review
  11. Article
  12. Article
  13. Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice.Journal of molecular neuroscience : MN · 2018
    Review
  14. PACAP38 and PACThe journal of headache and pain · 2018
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nicole NemetzDepartment of Laboratory Animal Medicine, David Geffen School of Medicine, Semel Institute for Neuroscience and Mental Retardation Research Center, University of California at Los Angeles, CA 90095, USA.
Catalina Abad
Greg Lawson
Hiroko Nobuta
Seririthanar Chhith
Lucy Duong
Gary Tse
Jonathan Braun
James A Waschek

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
VIP AND PACP ACTION IN CNS DEVELOPMENT AND INJURYP01HD006576 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DE VELLIS, JEAN · 1985 to 2006
$7.8M
REGULATION OF NEURAL PRECURSORS: ROLE OF NEUROPEPTIDESR01HD034475 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASCHEK, JAMES A · 1997 to 2006
$1.6M
PKA modulation of hedgehog: mouse medulloblastoma modelR01CA110384 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASCHEK, JAMES A · 2005 to 2009
$1.5M
NCI NIH HHS CA110384NCI NIH HHS P30 CA016042NCI NIH HHS R01 CA110384NICHD NIH HHS HD06576NICHD NIH HHS HD34475NICHD NIH HHS P01 HD006576NICHD NIH HHS R01 HD034475
6 · The paper itself

Abstract

Pituitary adenylyl cyclase activating peptide (PACAP) is expressed in central, sensory, autonomic, and enteric neurons. Although it classically acts as a neurotransmitter/neuromodulator, recent studies indicate that PACAP can also regulate immune function. To this effect, PACAP has been shown to reduce clinical symptoms and inflammation in mouse models of human immune-based diseases such as rheumatoid arthritis, Crohn's Disease, septic shock and multiple sclerosis. Despite these findings, the role of the endogenous peptide in regulating immune function is unknown. To determine if endogenous PACAP plays a protective role in inflammatory bowel disease (IBD) and IBD-associated colorectal cancer in mice, PACAP-deficient (KO) mice were subjected to 3 cycles of dextran sulfate sodium (DSS) in drinking water over 2 months, an established mouse model for colitis. Compared to wild type (WT) controls, PACAP KO mice exhibited more severe clinical symptoms of colitis and had significantly higher colonic inflammation on pathological examination. Moreover, 60% of the PACAP KO mice developed colorectal tumors with an aggressive-appearing pathology. Consistent with published data, DSS-treated WT mice did not develop such tumors. The results demonstrate a new mouse model which rapidly develops inflammation-associated colorectal cancer in the absence of a carcinogen.

Indexed as

AnimalsColitisColorectal NeoplasmsDextran SulfateGene Expression RegulationInflammatory Bowel DiseasesInterleukin-1betaInterleukin-6MicePituitary Adenylate Cyclase-Activating PolypeptideRandom AllocationSeverity of Illness IndexTumor Necrosis Factor-alphaAdcyap1 protein, mouseDextran SulfateInterleukin-1betaInterleukin-6Pituitary Adenylate Cyclase-Activating PolypeptideTumor Necrosis Factor-alpha

Identifiers

PMID18098289
PMCPMC3752983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.